Properties
Description
JNJ-42041935 is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth.
Molecular Formula
C12H6ClF3N4O3
Identity
Confirmed by NMR/HPLC/MS.
Applications
JNJ-42041935 is employed as a HIF inhibitor to explore treatments for ischemic and neoplastic diseases.